Gresham Richter, MD, FACS, FAAP is a Professor, Vice Chair, and Chief of Pediatric Otolaryngology in the Department of Otolaryngology-Head and Neck Surgery at the University of Arkansas for Medical Sciences (UAMS) and Arkansas Children’s (AC). He is the distinguished recipient of the Hamlen and Siebert Endowed Chair in Pediatric Otolaryngology and the past chair-holder of the Benjamin and Milton Waner Endowed Chair in Pediatric Facial Plastics and Reconstructive Surgery. He has received numerous clinical and research awards including recognition for Best Doctor’s in America for the past 5 years. He maintains a very busy clinical practice in pediatric otolaryngology and vascular anomalies, fields in which he has published over 90 manuscripts, 2 books, and 30 book chapters. Dr. Richter received his undergraduate and medical degrees at the University of Colorado. He completed his residency in Otolaryngology at UAMS and a fellowship in Pediatric Otolaryngology at Cincinnati Children’s Hospital. He returned to Arkansas to join UAMS faculty and founded the Arkansas Vascular Biology Program, a robust laboratory at AC dedicated to understanding and discovering new therapies for complex vascular lesions. He holds numerous administrative positions including the President of the Child’s Health Organization and Director of the Vascular Anomalies Clinic and Research Center at AC. Outside of the hospital, Dr. Richter is an entrepreneur and CEO of GDT Innovations. He serves on the board of several national and international associations and is a happily married husband and father of three children.

Dr. Richter is the Chief of Pediatric Otolaryngology, Vascular Anomalies Clinic and Research Director at the University of Arkansas for Medical Sciences (UAMS) and Arkansas Children’s Hospital (ACH). He is a Professor in the UAMS College of Medicine and holds the Benjamin & Milton Waner Endowed Chair in Pediatric Facial Plastic & Reconstructive Surgery at ACH. Dr. Richter is the Founder and Director of the Arkansas Vascular Biology Program, a research center dedicated to investigating normal and abnormal vascular development at Arkansas Children's Research Institute. This center maintains over 700 square feet of laboratory space with dedicated personnel (Research specialist, 2 x MD-PhD scientists) to develop experimental models and identify genetic and molecular targets for lymph and blood vasculature.

Research Director at the University of Arkansas for Medical Sciences (UAMS) and Arkansas Children’s Hospital (ACH). He is a Professor in the UAMS College of Medicine and holds the Benjamin & Milton Waner Endowed Chair in Pediatric Facial Plastic & Reconstructive Surgery at ACH. Dr. Richter is the Founder and Director of the Arkansas Vascular Biology Program, a research center dedicated to investigating normal and abnormal vascular development at Arkansas Children's Research Institute. This center maintains over 700 square feet of laboratory space with dedicated personnel (Research specialist, 2 x MD-PhD scientists) to develop experimental models and identify genetic and molecular targets for lymph and blood vasculature.

Dr. Richter is a head and neck surgeon with 50% percent of his clinical time dedicated to the treatment of children with vascular anomalies and head and neck tumors. He is an avid researcher with over 100 publications, 2 textbooks, and 30 book chapters of which many are directed to the fields of pediatric otolaryngology, vascular anomalies, and head and neck cancer. Dr. Richter and his collaborators have been awarded numerous grants and scientific prizes for their research. He has been an invited speaker at national and international organizations, holds several institutional leadership positions, and on the board of two national and one international organization.

Dr. Richter’s professional interests lie in the identification of a cure for vascular anomalies by select targeting of the anomalous vasculature present in these lesions. His bench-top and clinical research currently examines aberrant blood and lymphatic channels in vascular tumors and malformations. Pilot work has led to published in vitro and in vivo experimental models with genetic and molecular characterization of vascular anomalies. In close collaboration with his colleagues, Dr. Horacio Gomez-Acevedo and Dr. Stewart MacLeod, Dr. Richter is directing his investigations into high-throughput sequencing technologies (e.g., whole exome sequencing) to identify therapeutic targets of vascular malformations. Dr. Gomez-Acevedo is a well-established expert in bioinformatics whereas Dr. MacLeod has decades of experience microbiology and genomic research with expertise in Illumina sequencing. This collaboration provides a coalition of laboratories with clinical, bioinformatics, and molecular biology expertise in identifying novel genetic or epigenetic approaches to direct the pharmacologic treatment of congenital disorders of vascular development.

All patient satisfaction surveys are submitted by verified patients and families of Arkansas Children's. The star rating is an average of all responses to the provider-related questions by an independent patient satisfaction company. Responses are measured on a scale of 1 to 5 with 5 being the best score. The comments listed reflect the positive experiences submitted by patients and families through the survey process. The comments are not endorsed by and do not necessarily reflect the views or Arkansas Children's.

Learn more about this survey

loading...

Verified Patient Comments

loading...

Related Services

Show all 6 Items +

Related Blogs